Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA:600380)

Market Cap	17.22B -11.9%
Revenue (ttm)	14.85B -3.4%
Net Income	1.31B -4.9%
EPS	0.73 -0.6%
Shares Out	1.78B
PE Ratio	13.26
Forward PE	12.06
Dividend	0.22 (2.28%)
Ex-Dividend Date	Jul 18, 2025

Volume	11,018,673
Open	9.67
Previous Close	9.65
Day's Range	9.58 - 9.80
52-Week Range	9.56 - 14.21
Beta	0.19
Analysts	Strong Buy
Price Target	15.74 (+61.93%)
Earnings Date	Aug 26, 2026

About SHA:600380

Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China and internationally. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and traditional Chinese medicine, including cold medicine anti-viral granules and anti-tumor medicine. It also provides diagnostic reagents and equipment, such ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 13,575
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600380

Financial Performance

In 2025, SHA:600380's revenue was 15.22 billion, a decrease of -2.58% compared to the previous year's 15.62 billion. Earnings were 1.34 billion, a decrease of -3.68%.

Analyst Summary

According to 2 analysts, the average rating for 600380 stock is "Strong Buy." The 12-month stock price target is ¥15.74, which is an increase of 61.93% from the latest price.

Price Target

¥15.74

(61.93% upside)

Analyst Consensus: Strong Buy